Two alternative syntheses of 2-oxaadamantan-5-amine, a novel analog of the clinically approved drug amantadine, are reported. The compound has been tested as an anti-influenza A virus agent and as an NMDA receptor antagonist. While the compound was not antivirally active, it displayed moderate activity as an NMDA receptor antagonist.

Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog / R. Leiva, S. Gazzarrini, R. Esplugas, A. Moroni, L. Naesens, F.X. Sureda, S. Vazquez. - In: TETRAHEDRON LETTERS. - ISSN 0040-4039. - 56:10(2015 Mar), pp. 1272-1275. [10.1016/j.tetlet.2015.01.160]

Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog

S. Gazzarrini
Secondo
;
A. Moroni;
2015

Abstract

Two alternative syntheses of 2-oxaadamantan-5-amine, a novel analog of the clinically approved drug amantadine, are reported. The compound has been tested as an anti-influenza A virus agent and as an NMDA receptor antagonist. While the compound was not antivirally active, it displayed moderate activity as an NMDA receptor antagonist.
adamantane; amantadine; M2 channel; NMDA receptor antagonist; Ritter reaction
Settore BIO/09 - Fisiologia
mar-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0040403915002105-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 546.38 kB
Formato Adobe PDF
546.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1049271
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact